Management of Anticoagulation during Extracorporeal Membrane Oxygenation in Children
Extracorporeal Membrane Oxygenation (ECMO) is often used in critically ill children with severe cardiopulmonary failure. Worldwide, about 3600 children are supported by ECMO each year, with an increase of 10% in cases per year. Although anticoagulation is necessary to prevent circuit thrombosis duri...
Main Authors: | Madhuradhar Chegondi, Niranjan Vijayakumar, Balagangadhar R. Totapally |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Pediatric Reports |
Subjects: | |
Online Access: | https://www.mdpi.com/2036-7503/14/3/39 |
Similar Items
-
Anticoagulation and pediatric extracorporeal life support (ECLS). A review of current practice and recommendations
by: Vishal Singh, et al.
Published: (2017-01-01) -
A Systematic Literature Review of Packed Red Cell Transfusion Usage in Adult Extracorporeal Membrane Oxygenation
by: Thomas Hughes, et al.
Published: (2021-03-01) -
Management of massive airway hemorrhage associated with extracorporeal membrane oxygenation: A retrospective case series study
by: Hong Zhou, et al.
Published: (2023-06-01) -
International treatment outcomes of neonates on extracorporeal membrane oxygenation (ECMO) with persistent pulmonary hypertension of the newborn (PPHN): a systematic review
by: Saad Alhumaid, et al.
Published: (2024-08-01) -
Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review
by: Carlos A. Valdes, et al.
Published: (2023-03-01)